Lectures 1–2 — Review of General Microbiology, and Antibiotics and Resistance.
| Term | What you need to know |
|---|---|
| Prokaryotic vs eukaryotic | PRO: no nuclear membrane, few organelles, circular naked DNA, peptidoglycan wall, 70S ribosomes. EU: nuclear membrane, many organelles, linear DNA + histones, carbohydrate wall, 80S ribosomes. |
| The five types | Bacteria (prokaryotic) · fungi, protozoa, helminths (eukaryotic) · viruses (noncellular infectious agents). |
| Chlamydias vs Rickettsias | Both tiny obligate intracellular. Rickettsias ARE arthropod-transmitted (fleas, ticks, lice); Chlamydias are NOT. |
| Mycoplasmas | Tiny, pleomorphic, LACK A CELL WALL. M. pneumoniae. |
| Fungi | Yeasts unicellular (Candida albicans) · molds multicellular and filamentous (Penicillium notatum). |
| Protozoa | Trophozoite = motile feeding; cyst = dormant resistant. Apicomplexa essentially nonmotile — Plasmodium. |
| Helminths | Flatworms: no body cavity, blind-pouch gut. Roundworms: complete gut, cuticle, spines and hooks. |
| Prion vs viroid | PRION = misfolded protein, NO nucleic acid. VIROID = short RNA, NO protein coat, plants only. |
| Term | What you need to know |
|---|---|
| Flagellum / pilus / fimbriae | Motility · plasmid-coded, CONJUGATION · adhesion to membranes. |
| Glycocalyx | Biofilms · prevents desiccation · prevents phagocytosis (pathogenicity factor). |
| Plasmids | Small circular dsDNA, NOT essential. May encode antibiotic resistance, metal tolerance, enzymes, toxins. |
| Endospores | Survival mechanism. BACILLUS and CLOSTRIDIUM. |
| Term | What you need to know |
|---|---|
| Peptidoglycan | NAG + NAM alternating, crosslinked by a short peptide bridge. TRANSPEPTIDASES = target of beta lactams. |
| Steps | Crystal violet → iodine → DECOLORIZE acetone alcohol ~10s (MOST CRITICAL) → safranin. |
| Gram positive | Thick peptidoglycan + teichoic acids. RETAINS crystal violet → purple. PHYSICALLY strong. |
| Gram negative | Outer membrane (LPS) + periplasm + thin peptidoglycan. LOSES it → red. CHEMICALLY strong. |
| Lipopolysaccharide | LIPID A (endotoxin) · core polysaccharide · O-POLYSACCHARIDE (classification). |
| Term | What you need to know |
|---|---|
| Growth | Increase in NUMBER, not size, by binary fission → exponential. |
| Four phases | Lag (adjustment) → exponential (MOST VULNERABLE, e.g. penicillin) → stationary (growth = death) → death (exponential, in own wastes). |
| Death curve | Rate of death under a control method is CONSTANT. Decimal reduction time = time to kill 90%. |
| Term | What you need to know |
|---|---|
| 6 phage steps | Adsorption → penetration → replication → assembly → maturation → release. |
| Lytic vs lysogenic | LYTIC: host destroyed, generalized transduction. LYSOGENIC: prophage, may gain a toxin gene, immune to reinfection, specialized transduction. |
| Animal vs phage | Entire virion ENGULFED · UNCOATING required · release by BUDDING. |
| Term | What you need to know |
|---|---|
| Antibiotic (precisely) | A substance PRODUCED BY A MICROBE that in small amounts inhibits another microbe. Antimicrobial drug = interferes with microbial growth in a host. Chemotherapy = use of drugs to treat disease. |
| MBC vs MIC | MBC = minimum level killing 99.9% of test organisms (bactericidal). MIC = minimum level inhibiting growth (bacteriostatic). |
| What makes a good agent | Selective toxicity · favorable pharmacokinetics · appropriate spectrum · few side effects · low toxicity · low hypersensitivity · good therapeutic index · LITTLE resistance development. |
| Eukaryotic pathogens | Harder — cell structure and physiology resemble the host, so great possibility of toxic side effects. Fewer drugs available. |
| Choosing the agent | Kirby Bauer disk diffusion (zone corrected for concentration, molecular weight, diffusion). E test = MIC read directly in µg/ml where the zone meets the strip. |
| Term | What you need to know |
|---|---|
| Therapeutic window | Range of plasma concentrations spanning minimum concentration for efficacy and for toxicity. |
| Therapeutic index | TI = max tolerated dose ÷ MIC = TD50 ÷ ED50. HIGHER = wider safety margin = safer drug. |
| Drug clearance | Renal + hepatic + all other tissues. Drives dosing: do NOT let concentration fall below MIC, and remember onset is not instant. |
| Term | What you need to know |
|---|---|
| Fungi produce | Penicillin ← Penicillium chrysogenum · cephalosporins ← Cephalosporium acremonium · griseofulvin ← Penicillium griseofulvum. |
| Gram-positive rods produce | Bacitracin ← Bacillus subtilis · polymyxin ← Paenibacillus polymyxa. |
| Actinomycetes produce (most) | Chloramphenicol ← S. venezuelae · streptomycin ← S. griseus · neomycin ← S. fradiae · tetracycline ← S. aurofaciens · amphotericin B ← S. nodosus · nystatin ← S. noursei. |
| THE TWO EXCEPTIONS | Gentamycin ← MICROMONOSPORA purpurea. Erythromycin ← SACCHAROPOLYSPORA erythraea. Both non-Streptomyces — high yield. |
| Other | Vancomycin ← Amycolatopsis orientalis · rifamycin ← Amycolatopsis rifamycinica. Quinolones and sulfonamides are ARTIFICIAL (sulfa from coal tar dyes, Domagk 1935). |
| Term | What you need to know |
|---|---|
| 5 targets | Cell wall · protein synthesis · nucleic acid · plasma membrane · essential metabolites. |
| Cell wall | Penicillins (PBPs, transpeptidase, autolysins) · cephalosporins (1st Gram+ → 4th oral) · bacitracin (bactoprenol; TOPICAL only) · vancomycin (binds NAG/NAM; last line vs resistant S. aureus) · isoniazid (mycolic synthesis) vs ethambutol (its incorporation). |
| Protein synthesis | Chloramphenicol 50S peptide bond · aminoglycosides 30S codon misreading · tetracyclines tRNA attachment · streptogramins TWO components on 50S · erythromycin 50S translocation. |
| Nucleic acid | Rifamycin — RNA polymerase (TB). Quinolones — DNA GYRASE (UTI, hospital-acquired). |
| Membrane / metabolites | Polymyxin B — attaches lipid components of outer + inner membrane (topical). Sulfonamides — mimic PABA, block folate. |
| Antifungals | POLYENES bind ergosterol → pores. AZOLES block ergosterol SYNTHESIS. ECHINOCANDINS block beta-glucan (CELL WALL, not membrane). Griseofulvin — microtubules. Tolnaftate — squalene epoxidase. |
| Antivirals | Remdesivir — nucleotide analog, terminates RNA transcription · protease inhibitors · integrase inhibitors · CCR5 block (attachment) · neuraminidase (escape) · amantadine (uncoating) · interferon (alpha in hepatitis; PEG = finite duration BUT greater adverse effects). |
| Term | What you need to know |
|---|---|
| Resistance defined | Avoiding an antibiotic's effects by DESTROYING it, TRANSPORTING it out, or CHANGING to block it. |
| Why it occurs | Genetic variation means some are already less susceptible; the antibiotic SELECTS them. The drug does not create resistance. |
| Genetic mechanisms | Random mutation · plasmid swapping (conjugation) · transposons · transduction · transformation · binary fission shares all. |
| Biochemical mechanisms | No access: decreased permeability (beta-lactams, quinolones), decreased transport (aminoglycosides), increased efflux (tetracyclines, quinolones). Inactivation: beta-lactamases. Target modification: gyrase. Bypass: vanA, vanB, TMP. |
| Biofilms + ESKAPE | Barrier sequesters drug · organisms metabolically LESS active · proximity ENHANCES gene transfer. ESKAPE = E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, Enterobacter. |
| 4 problems with therapy | SUPERINFECTION · DIRECT TOXICITY · HYPERSENSITIVITY · RESISTANCE. |
| Direct toxicity (high yield) | Aminoglycosides = renal + AUDITORY · chloramphenicol = aplastic anemia · ciprofloxacin = seizures · doxycycline = esophageal ulcers · tetracycline = tooth discoloration (binds calcium during development) · amphotericin B = renal + hepatic · sulfamethoxazole = hyperkalemia · chloroquine = dysrhythmias. |
| Hypersensitivity | Mostly BETA LACTAMS (penicillin, cephalosporins) and quinolones. Immediate or delayed; hives → anaphylaxis. |
| Drug combinations | Indifference (no interaction) · SYNERGISM (greater than either) · ANTAGONISM (less than either). |
| Term | What you need to know |
|---|---|
| INFECTION vs DISEASE | INFECTION = microbes PENETRATE HOST DEFENSES, ENTER TISSUES AND MULTIPLY. DISEASE = ANY DEVIATION FROM HEALTH, microbial or not. Disease is the BROADER term. |
| RESIDENT FLORA | Bacteria, fungi, protozoa, viruses AND ARTHROPODS. Most areas in contact with the outside environment carry them. |
| HIGHEST NUMBERS | LARGE INTESTINE — mainly STRICT or FACULTATIVE ANAEROBES. Bacteria are 10–30% OF FECAL VOLUME. |
| Skin flora | STAPHYLOCOCCI, CORYNEBACTERIUM, PROPIONIBACTERIUM, YEASTS, MYCOBACTERIUM SMEGMATIS. |
| Oral flora | AEROBIC STREPTOCOCCI are the most common oral residents. |
| Respiratory flora | STAPH. AUREUS, NEISSERIA MENINGITIDIS. The LOWER RESPIRATORY TRACT IS ESSENTIALLY STERILE. |
| STERILE SITES | Heart and blood vessels · kidneys and bladder · brain and spinal column · middle and inner ear · interior of the eyes · BLOOD AND CSF (cerebrospinal fluid) · urine in the kidneys and bladder · AMNIOTIC FLUID. |
| The numbers | ~30 TRILLION human cells vs ~38 TRILLION non-human. ~50% of the human genome is NON-HUMAN genetic material. |
| Term | What you need to know |
|---|---|
| TRUE (FRANK) PATHOGEN | Causes disease in HEALTHY people with NORMAL defenses. INFLUENZA, RABIES, PLAGUE BACTERIUM, MALARIAL PROTOZOAN. |
| OPPORTUNISTIC PATHOGEN | Causes disease when defenses are COMPROMISED, or when it grows somewhere UNNATURAL to it. SOMETIMES IT IS THE PATIENT'S OWN FLORA. |
| WEAKENS HOST DEFENSES | AGE (elderly, young children, premature infants) · genetic/acquired immunological defects · IMMUNOSUPPRESSING DRUGS AND ORGAN TRANSPLANTS · STRESS · chronic conditions (liver disease, diabetes) · INFLAMMATION · primary infections. Write them as COMORBIDITIES. |
| PORTALS OF ENTRY | SKIN · GASTROINTESTINAL · RESPIRATORY · UROGENITAL · CONJUNCTIVA · PREGNANCY AND BIRTH. EXOGENOUS (outside) or ENDOGENOUS (within). |
| INFECTIOUS DOSE (ID50) | MINIMUM microbes needed to infect 50% of a population. SMALL ID50 = GREATER VIRULENCE. |
| The ID50 range | MEASLES 1 PARTICLE · TB 10 bacteria · smallpox 10–100 · plague 100–500 · SARS-CoV-1 ~280 · influenza A ~790 · gonorrhea 1,000 · CHOLERA 100,000,000. |
| ADHESION MECHANISMS | FIMBRIAE (attachment pili) · FLAGELLA · ADHESIVE SLIMES/CAPSULES (dextran slime, glycocalyx) · SUCTION DISKS of protozoans · VIRAL SPIKE or CAPSID PROTEINS · HOOKS AND BARBS of helminths and insect larvae. |
| Term | What you need to know |
|---|---|
| ENDOTOXIN — what | LIPID A OF THE LIPOPOLYSACCHARIDE. |
| ENDOTOXIN — who | GRAM-NEGATIVE ONLY. It is part of their outer membrane. |
| ENDOTOXIN — released how | FROM LYSED OR DAMAGED bacteria — i.e. when the organism DIES. |
| EXOTOXIN — what | PROTEINS. |
| EXOTOXIN — who | Certain GRAM-POSITIVE AND GRAM-NEGATIVE bacteria. |
| EXOTOXIN — released how | SECRETED BY LIVING bacteria. |
| The one-liner | ENDO = STRUCTURAL LIPID FROM A DEAD GRAM-NEGATIVE. EXO = PROTEIN SECRETED BY A LIVING ORGANISM, EITHER GRAM. |
| EXOENZYMES | Attack host defenses to allow DEEPER INVASION: MUCINASE, HYALURONIDASE, COAGULASE, BACTERIAL KINASES. |
| TOXIGENICITY | Capacity to produce toxins, grouped by TISSUE TARGETED: NEUROTOXINS, ENTEROTOXINS, HEMOTOXINS, NEPHROTOXINS. |
| ANTIPHAGOCYTIC FACTORS | LEUKOCIDINS destroy leukocytes (-cidin = to kill). CAPSULES avoid phagocytosis or resist digestion inside the phagocyte. |
| Term | What you need to know |
|---|---|
| LOCALIZED | Confined to a specific tissue. BOILS, WARTS. |
| SYSTEMIC | Spreads to SEVERAL SITES via the bloodstream. MEASLES, CHICKEN POX, ANTHRAX, RABIES. |
| FOCAL | An agent BREAKS LOOSE from a local site and spreads. |
| MIXED | SEVERAL MICROBES growing SIMULTANEOUSLY at one site. |
| PRIMARY / SECONDARY | PRIMARY = the initial infection. SECONDARY = a DIFFERENT microbe complicating it, e.g. bacterial lung infection on top of a viral URI. |
| SUPERINFECTION | A secondary infection from DISRUPTION OF THE NATURAL MICROFLORA. Classic: ANTIBIOTICS FOR STREP THROAT → VAGINAL YEAST INFECTION. IF THE STEM MENTIONS ANTIBIOTICS, IT IS A SUPERINFECTION. |
| SIGN | OBJECTIVE evidence noted by an OBSERVER; often more precise and MAY BE MEASURED. Example: INFLAMED PHARYNX. |
| SYMPTOM | SUBJECTIVE evidence SENSED AND DESCRIBED BY THE PATIENT. Example: SORE THROAT. |
| SEQUELAE | LONG-TERM OR PERMANENT damage: PARALYSIS from polio · BLINDNESS from gonococcal conjunctivitis · STERILITY from syphilis · DEAFNESS from meningitis · ARTHRITIS from Lyme disease. |
| PORTAL OF EXIT | How pathogens DEPART the host — and therefore how they reach the next one. |
| Term | What you need to know |
|---|---|
| RESERVOIR | The PRIMARY HABITAT from which a pathogen ORIGINATES. Living or nonliving. |
| Living reservoirs | Someone with an OBVIOUS ACTIVE INFECTION is likely contagious. ASYMPTOMATIC CARRIERS may be HUMANS OR ANIMALS. |
| PASSIVE CARRIERS | MEDICAL OR DENTAL PERSONNEL — carrying it without being infected. |
| VECTORS | A LIVE ANIMAL that transmits disease: MOSQUITOES, FLEAS, TICKS; also FLIES, FRUIT FLIES, COCKROACHES. |
| NONLIVING RESERVOIRS | SOIL AND WATER. |
| ZOONOSIS | Animal infections spread to humans and vice versa. Can be BACTERIAL, VIRAL, FUNGAL OR PROTOZOAN. CANNOT BE ELIMINATED WITHOUT ERADICATING THE ANIMAL RESERVOIR. |
| DIRECT transmission | HORIZONTAL (kissing, sexual) · VERTICAL (MOTHER TO CHILD, transplacental or vaginal birth) · DROPLET (saliva, vomit, feces, blood) · BIOLOGICAL VECTORS. |
| INDIRECT transmission | VEHICLES and FOMITES (inanimate objects), and AIRBORNE DROPLET NUCLEI. |
| Term | What you need to know |
|---|---|
| DEFINITION | HAI = HOSPITAL-ACQUIRED INFECTION. ACQUIRED OR DEVELOPING DURING A HOSPITAL STAY. May PROLONG THE STAY OR END IN DEATH. |
| MOST COMMON SITES | URINARY TRACT · RESPIRATORY TRACT · SURGICAL INCISIONS. |
| MOST COMMON ORGANISMS | Gram-negative: E. COLI, PSEUDOMONAS, KLEBSIELLA. Gram-positive: STAPHYLOCOCCI, STREPTOCOCCI. Fungi: YEASTS. The wider list goes by ESKAPE. |
| MITIGATION — the answer | UNIVERSAL PRECAUTIONS for sample collection and patient care, based on the assumption that ALL PATIENT SPECIMENS ARE POSSIBLY INFECTIOUS. You do not decide which to be careful with. |
| The fomite link | An INANIMATE OBJECT carries the organism between patients — which is why the same few organisms keep reappearing. |
| Term | What you need to know |
|---|---|
| EPIDEMIOLOGY | Study of the FREQUENCY AND DISTRIBUTION of disease in human populations. |
| REPORTABLE / NOTIFIABLE | Must be reported to PUBLIC HEALTH AUTHORITIES. In the US the CDC publishes the MORBIDITY AND MORTALITY WEEKLY REPORT. |
| PREVALENCE | TOTAL EXISTING cases against the entire population, usually A PERCENTAGE. |
| INCIDENCE | NEW cases OVER A TIME PERIOD, against the general healthy population. |
| MORTALITY RATE | DEATHS due to a disease, PER 100,000. |
| MORBIDITY RATE | CASES — people afflicted — PER 100,000. |
| THE 100-YEAR TREND | DEATH RATE DROPPED while MORBIDITY REMAINED RELATIVELY HIGH. People stopped DYING of these; they did not stop GETTING them. |
| ENDEMIC | STEADY frequency over a long period in a particular LOCATION, often because the RESERVOIR IS PRESENT. |
| SPORADIC | OCCASIONAL cases at IRREGULAR intervals. |
| EPIDEMIC | Prevalence INCREASING BEYOND WHAT IS EXPECTED for that population. |
| PANDEMIC | A GLOBAL epidemic. |
| KOCH'S POSTULATES (1880s) | 1. FIND the microbe in EVERY CASE. 2. ISOLATE and CULTIVATE IT ARTIFICIALLY. 3. INOCULATE a susceptible healthy subject. 4. RE-ISOLATE from the new subject. |
| WHERE KOCH FAILS | Organisms that CANNOT BE CULTIVATED ARTIFICIALLY — M. LEPRAE and LEGIONELLA PNEUMOPHILA. VIRUSES AND PRIONS break all the old rules. |
| MOLECULAR KOCH (Falkow, 1988) | 1. The PROPERTY should ASSOCIATE WITH PATHOGENIC STRAINS. 2. INACTIVATING the gene should cause MEASURABLE LOSS OF VIRULENCE. 3. REVERTING it should RESTORE pathogenicity. The shift is FROM THE ORGANISM TO THE GENE. |
| Term | What you need to know |
|---|---|
| THE SIX LINKS, IN ORDER | 1. INFECTIOUS AGENT → 2. RESERVOIR → 3. PORTAL OF EXIT → 4. MODE OF TRANSMISSION → 5. PORTAL OF ENTRY → 6. SUSCEPTIBLE HOST. Break ANY link and transmission stops. |
| LIVING reservoirs | HUMANS, ANIMALS — and the deck marks PLANTS and FUNGI with a question mark. |
| NON-LIVING reservoirs | SOIL, WATER, AIR, FOOD and FOMITES. |
| ACTIVE carrier | IS INFECTED, may or may not show symptoms. TYPHOID MARY (Mary Mallon) carried SALMONELLA TYPHI asymptomatically. |
| PASSIVE carrier | IS NOT INFECTED but still transmits — the healthcare or food worker with poor hand hygiene. THE DISTINCTION IS WHETHER THEY ARE INFECTED. |
| Term | What you need to know |
|---|---|
| ZOONOSIS | An ANIMAL infection that spreads to humans AND THE REVERSE. Can be BACTERIAL, VIRAL, FUNGAL or PROTOZOAN — all four. |
| WHY THEY CANNOT BE ERADICATED | You would have to eradicate the ANIMAL RESERVOIR too — harder with MULTIPLE reservoirs, and worse if the pathogen lies dormant as a FUNGAL SPORE or PROTOZOAN CYST. |
| HUMANS IN PLAGUE / ANTHRAX | The ACCIDENTAL HOST. |
| RABIES | Reservoir MAMMALS · BITE/SALIVA · human-to-human RARE (organ transplantation). |
| INFLUENZA | Reservoir BIRDS and PIGS · respiratory droplet and contact · human-to-human YES. |
| EBOLA / MARBURG / NIPAH | Reservoir FRUIT BATS (Ebola also small primates) · BODY FLUIDS · human-to-human YES. |
| COMMONEST ZOONOSIS | RABIES in the UNITED STATES; MALARIA WORLDWIDE. From the recording, not a slide. |
| VECTOR vs RESERVOIR | VECTOR = a LIVING thing that TRANSMITS (mosquitoes, fleas, ticks, flies, cockroaches). RESERVOIR HARBORS it. Malaria: birds may be the reservoir, MOSQUITOES the vector. |
| Term | What you need to know |
|---|---|
| DIRECT — VERTICAL | MOTHER TO CHILD. |
| DIRECT — HORIZONTAL | Usually MUCOUS MEMBRANE contact — sexual contact, kissing. Droplets: coughing, sneezing, saliva, blood, sweat, tears. |
| INDIRECT contact | Onto an INANIMATE SURFACE first — that is FOMITE transmission. |
| VEHICLE — FOOD | GI ILLNESS is the commonest result. |
| VEHICLE — WATER | Drinking water, plus POOLS, SPAS and WATER PARKS. |
| VEHICLE — SOIL | Contaminates produce, HANDS and FINGERNAILS; pinworms in children. |
| VEHICLE — AIR | Usually an INDOOR phenomenon. Ventilation, filtration and CROWDING matter. |
| Term | What you need to know |
|---|---|
| FOMITE | A NON-LIVING SURFACE OR OBJECT that may transmit pathogens. |
| HAI consequences | LONGER STAYS, long-term disability, PREVENTABLE DEATHS, expense, risk to safety AND quality of care. |
| HIGHEST-RISK groups | IMMUNOCOMPROMISED, pediatric, geriatric, HIV, OPEN WOUNDS or BURNS, surgical patients. |
| CATHETERS | Indwelling devices are the problem because STAPH. AUREUS and STAPH. EPIDERMIDIS form BIOFILMS. |
| Clinical fomites | Scalpels, syringes, CATHETERS, bed rails, gurneys, PHONES, remotes, KEYBOARDS, floors, mops, pillows, bedding, CURTAINS, STETHOSCOPES, NECKTIES, stuffed animals, greeting cards, FLOWERS. |
| NOT JUST HOSPITALS | A public restroom, HOTEL ROOM, cruise ship cabin or AEROPLANE TRAY TABLE is a fomite-filled room too. |
| Term | What you need to know |
|---|---|
| BIRTHDAY CAKE (Dawson 2017) | Blowing out candles → 15× MORE bacteria on the frosting vs the no-blow control. THEY NEVER IDENTIFIED THE ORGANISMS. Said nothing about fungi or VIRUSES in saliva. |
| THE CANDLE TEST | Try blowing out a candle WHILE WEARING a face covering — the droplet-size demonstration. |
| KEYBOARDS (Ide 2019) | 75 studies reviewed. Keyboards, mice/pads, tablets. Grew COLIFORMS (E. coli) and MRSA. |
| VIRAL FOMITES (Boone & Gerba 2007) | 1.7M deaths/yr diarrheal, 1.5M respiratory. VIRUSES CAUSE ~60% OF HUMAN INFECTIONS and CANNOT be cured with antibiotics. CROWDED INDOOR SPACES consistently INCREASE morbidity and mortality. |
| PATIENT ITEMS (Kanamori 2017) | Soap/sanitizer dispensers, humidifiers, nebulizers, pressure transducers, STETHOSCOPES, suction, THERMOMETERS, ULTRASOUND PROBE AND GEL, BP monitors, IV pumps, telemetry wires. |
| CFU | COLONY-FORMING UNIT — used because you cannot know if a colony began from ONE cell or a THOUSAND. Reported per GRAM or per mL. |
| Term | What you need to know |
|---|---|
| FIVE BEST PRACTICES, in order | 1. STANDARDIZE cleaning policy · 2. Select EPA-REGISTERED disinfectants · 3. Educate ALL staff INCLUDING environmental services · 4. MONITOR compliance with feedback · 5. NO-TOUCH decontamination technology. |
| SEMMELWEIS, 1840s | Handwashing with CHLORINE solution, by obstetricians. |
| LISTER, 1860s | Handwashing and wound treatment with CARBOLIC ACID. |
| CHEMICAL AGENTS | Bleach, quaternary ammonium salts, phenolics — work ONLY at the CORRECT CONCENTRATION and for ADEQUATE CONTACT TIME. They are toxic. |
| OZONE / H2O2 / STEAM | THE ROOM MUST BE VACANT to reduce harm to humans. Time-consuming; can damage surfaces and devices. |
| COATINGS | From MARINE ANTI-FOULING paint (copper, arsenic, mercury, tin since the 1960s). ANTI-FOULING PREVENTS ATTACHMENT; ANTIMICROBIAL KILLS. Must be NONTOXIC, cost effective, available, STABLE and DURABLE. |
| Term | What you need to know |
|---|---|
| WHAT DRIVES MDR | EXTENSIVE ANTIBIOTIC USE. MDR, XDR and TDR strains — MRSA and CRKP — are especially problematic in hospitals. |
| BIOFILM | A POLYMICROBIAL NETWORK resistant to CLEANING, HEAT and ANTIMICROBIAL DRUGS. Staphylococcus and Pseudomonas form them. |
| THE CORE ARGUMENT | A fomite carrying a persistent pathogen CANNOT BE TOLD APART FROM A CLEAN SURFACE. |
| ANTISEPTIC STUDY (Lompo 2023) | Burkina Faso and Benin. LIQUID SOAP most contaminated — 51 of 69 samples. Risks: inconsistent preparation, RECYCLED soft-drink bottles, broken pumps, TOPPING UP. |
| >10,000 CFU/mL organisms | KLEBSIELLA PNEUMONIAE, PSEUDOMONAS AERUGINOSA, ACINETOBACTER — all GRAM-NEGATIVE. From MATERNITY, NEONATOLOGY, SURGERY and INTERNAL MEDICINE. |
| CONJUGATION | Donor and recipient NEED NOT be the same genus or species. Once a cell gains a resistance plasmid, ALL its offspring have it. |
| TRANSFORMATION | COMPETENT cells take up DNA fragments FROM THE ENVIRONMENT. A lesser factor. |
| TRANSDUCTION | Requires a BACTERIOPHAGE acting as the vector. |
| Term | What you need to know |
|---|---|
| How this list exists | The last three minutes of the lecture are a revision plan. These are his words, in his order. |
| 1. THE THREE LINES | “Know those three lines — first, second, third — and KNOW WHAT BELONGS IN EACH. First line: know which are PHYSICAL, which are CHEMICAL, which are MICROBIOLOGICAL.” |
| 2. RECOGNITION | “What do we call the receptors that the white blood cells have?” → PATTERN RECOGNITION RECEPTORS (PRRs), detecting PAMPs and DAMPs. |
| 3. MACROPHAGE vs NEUTROPHIL | “Know the difference between a macrophage and a neutrophil, our two major phagocytes. But HOW are they different?” |
| 4. THE DIFFERENTIAL | “What do we USE it for? And what can it TELL us?” |
| 5. INFLAMMATION | “Know the major characteristics AND HOW DO THEY COME ABOUT? How is it that we have the redness, the heat, the pain?” |
| 6. FEVER | “What CAUSES fever? Why is fever GOOD? Why is fever BAD?” |
| 7. INTERFERON | “WHEN do we produce interferon? What kind of invading organism?” → VIRUS. And: “remember that IT DOES NOT KILL A VIRUS, but it prevents the viral spread.” |
| 8. COMPLEMENT | “Three pathways, ALL GETTING TO C3. Which is first? THE ALTERNATIVE. Then the LECTIN. Then the CLASSICAL — and the classical is the one associated with the THIRD line of defense.” |
| ★ THE ORDER MATTERS | “Organisms have to hit these barriers IN ORDER — physical and chemical first, then the white blood cell processes, and ONLY AFTER that can they start an adaptive response.” A sequence, not a menu. |
| ✗ NOT asked to memorize (1) | The TYPES OF MUCINS — only that different surfaces get different ones. |
| ✗ NOT asked to memorize (2) | The CHART OF TOXINS defensins can unfold. |
| ✗ NOT asked to memorize (3) | The proteins protecting human cells from the MEMBRANE ATTACK COMPLEX — “you don’t need to fuss about that one.” |
| ✗ NOT asked to memorize (4) | The MAC ASSEMBLY CHART — just know it forms a PORE. |
| ✗ NOT asked to memorize (5) | The REFERENCE RANGES for the differential. The PROPORTIONS matter; the numbers do not. |
| Term | What you need to know |
|---|---|
| FIRST LINE | PHYSICAL, CHEMICAL, MICROBIOLOGICAL and GENETIC barriers AT THE PORTAL OF ENTRY. NONSPECIFIC. |
| SECOND LINE | Protective CELLS, physiological processes, antimicrobial substances. NONSPECIFIC. |
| THIRD LINE | ACQUIRED on exposure to ANTIGENS — antibodies or defensive cell lines, and IMMUNOLOGICAL MEMORY. SPECIFIC. |
| THE ONE-LINE VERSION | TWO of the three lines are NONSPECIFIC. Only the THIRD is specific. |
| THE ORGANIZING IDEA | Innate immunity covers a huge range WITHOUT a receptor per organism — it recognizes PATTERNS SHARED ACROSS PATHOGEN FAMILIES. |
| Term | What you need to know |
|---|---|
| EPIDERMIS | STRATIFIED SQUAMOUS. RAPID DESQUAMATION sheds transient flora. KERATIN works because MOST PATHOGENS LACK KERATINASE. |
| KERATINOCYTES | Make ANTIMICROBIAL PEPTIDES, packed into LAMELLAR BODIES, secreted into a WATERPROOF LIPID LAYER. |
| MUCOUS MEMBRANES | MUCH GREATER AREA than skin. THIN, PERMEABLE, NOT KERATINIZED — the price of gas exchange and absorption. |
| MUCUS / MUCINS | Glycoproteins, proteoglycans, peptides, enzymes. MUCINS = the GIGANTIC GLYCOPROTEINS. Made by the GUT GOBLET CELL. |
| LACRIMAL APPARATUS | Washes the eye AND carries LYSOZYME — physical and chemical at once. |
| URINE | Mechanical flush + HIGH OSMOLALITY + inhibitory pH. |
| LYSOZYME acts on | PEPTIDOGLYCAN. |
| SEMEN | SPERMINE, LYSOZYME, LACTOFERRIN, PHOSPHOLIPASE. |
| VAGINAL SECRETIONS | LACTIC ACID, BETA DEFENSIN, HYDROGEN PEROXIDE. (Easy to swap with the semen list — don’t.) |
| NORMAL FLORA — BOTH barriers | COMPETES for space and nutrients (PHYSICAL) and makes ANTIMICROBIAL SUBSTANCES (CHEMICAL). Colonization begins AFTER BIRTH. |
| SKIN FLORA | STAPH EPIDERMIDIS, other COAGULASE-NEGATIVE staphs, CORYNEFORM bacteria. |
| ★ ATOPIC DERMATITIS | DYSBIOSIS with LESS antimicrobial peptide. Colonizing with COAGULASE-NEGATIVE STAPHS DIMINISHED STAPH AUREUS. |
| GUT COMMENSALS — 3 extras | DIGEST what we cannot · PROVIDE VITAMINS · help develop GALT. |
| Term | What you need to know |
|---|---|
| COAGULATION | Clot LIMITS PATHOGEN MOBILITY, reduces blood/fluid loss. |
| KININ | Produces BRADYKININ — dilates vessels, relaxes smooth muscle. |
| PROTEASE INHIBITORS | Block MICROBIAL proteases. ONE TENTH of all serum proteins. Example: ALPHA-2 MACROGLOBULIN. |
| DEFENSINS — size & mechanism | 30–40 AMINO ACIDS, AMPHIPATHIC — they DAMAGE MEMBRANES. |
| DEFENSINS — range | BACTERIA, FUNGI, and ENVELOPED VIRUSES (an envelope IS a membrane). |
| DEFENSINS — ANTICHAPERONES | The ONLY innate components that NEUTRALIZE A BROAD RANGE OF TOXINS BY UNFOLDING THEM. |
| ★ THE GENETIC DEFENSE | GENE COPY NUMBER varies: 2–14 alpha, 2–12 beta. COPY NUMBER DETERMINES HOW MUCH PROTEIN. |
| ALPHA DEFENSIN LOCATIONS | 4 of 6 in NEUTROPHIL GRANULES; the other 2 from intestinal PANETH CELLS. |
| PENTRAXINS | Bind pathogens and TARGET THEM FOR PHAGOCYTOSIS. SHORT = HEPATOCYTES (serum amyloid P, C-REACTIVE PROTEIN). LONG = myeloid/endothelial/epithelial. |
| ACUTE-PHASE — the signal | Bacteria → MACROPHAGES make IL-6 → LIVER raises defensive proteins and LOWERS ALBUMIN. |
| ★ CRP and SERUM AMYLOID A | Rise OVER 100-FOLD. That is why CRP is used for infection, inflammation and TISSUE DAMAGE. CRP is a PENTRAXIN OPSONIN. |
| Term | What you need to know |
|---|---|
| THREE things to sort | HEALTHY SELF · NON-SELF · ALTERED SELF (virus-infected or cancerous). |
| PRR | PATTERN RECOGNITION RECEPTOR. |
| PAMP | PATHOGEN ASSOCIATED MOLECULAR PATTERN — marks NON-SELF. |
| DAMP | DAMAGE ASSOCIATED MOLECULAR PATTERN — marks ALTERED SELF. |
| WHY PATTERNS | Each receptor sees a pattern shared by a pathogen FAMILY — that is how a limited set covers a wide range. |
| MACROPHAGES are best at | BACTERIAL and FUNGAL CARBOHYDRATES, via LECTIN RECEPTORS. |
| NK CELLS are best at | CHANGED CELL SURFACE PROTEINS on virus-infected cells. |
| ★ TOLL-LIKE — location decides | ON THE SURFACE → INFLAMMATORY CYTOKINES. IN ENDOSOMES → INTERFERON. |
| RIG (retinoic acid inducible gene) | Detects VIRAL RNA → interferon. |
| CYCLIC GMP CYCLASE | Detects VIRAL DNA → interferon. |
| SCAVENGER RECEPTORS | Eliminate microbes — or, with NO infection, CELLULAR DEBRIS and APOPTOTIC CELLS. |
| Term | What you need to know |
|---|---|
| FIVE CARDINAL SIGNS | RUBOR (redness) · CALOR (heat) · TUMOR (swelling) · DOLOR (pain) · FUNCTIO LAESA (loss of function). |
| INFLAMMASOME | Macrophage senses infection → protein structure converts PRO IL-1β → FUNCTIONAL IL-1β in LARGE QUANTITIES. |
| ★ HOW IL-1β GETS OUT | PORES form in the macrophage membrane — and the cell DIES by PYROPTOSIS. |
| INFLAMMASOME MUTATIONS | Cause AUTOINFLAMMATORY DISEASES. |
| TNF-α | DILATES vessels → heat, swelling, redness, pain. |
| IL-6 | Increases TEMPERATURE. |
| CHEMOKINES | CXCL8, CCL2, IL-12 — attract other white cells. |
| EXTRAVASATION — step 1 ROLLING | L-SELECTIN (leukocyte) → CD34 vascular addressin (endothelium). |
| EXTRAVASATION — step 2 FIRM | LFA-1 integrin → ICAM-1 immunoglobulin-like molecule. |
| EXTRAVASATION — step 3 | DIAPEDESIS — squeezing between endothelial cells, guided by chemokines. |
| FEVER — the three pyrogens | IL-1β, IL-6, TNF-α. |
| ★ FEVER — THE 5 BENEFITS | (1) DECREASES viral and bacterial replication — in BACTERIA by STARVING THEM OF IRON. (2) MORE NEUTROPHILS. (3) MORE T CELL PROLIFERATION. (4) BETTER IMMUNE SIGNALING. (5) ENHANCES TISSUE RESISTANCE TO TNF-α DAMAGE. |
| ★ TNF-α LOCAL vs SYSTEMIC | LOCAL: clots blood in venules → PREVENTS SPREAD TO THE BLOOD. SYSTEMIC: all tissues at once → SHOCK, ORGAN FAILURE, DEATH. |
| Term | What you need to know |
|---|---|
| THE BASICS | 30+ PROTEINS, ubiquitous in blood and lymph, circulating as inactive ZYMOGENS, activated by CLEAVAGE in a cascade. |
| WHAT MAKES IT WORK | A unique HIGH-ENERGY THIOESTER BOND. |
| ★ THE THIOESTER BOND | C3 cleaved → C3a + C3b, exposing the bond on C3b. Attacked by WATER → soluble, useless. Reacts with a HYDROXYL or AMINO group on a pathogen → COMPLEMENT FIXATION. |
| C3a does | RECRUITS PHAGOCYTES. |
| ORDER OF ACTIVATION | ALTERNATIVE (1st, quickest) → LECTIN (2nd) → CLASSICAL (last). DISCOVERED in a different order: classical, alternative, lectin. |
| ALL THREE CONVERGE ON | CLEAVING C3 — by far the most important molecule in the cascade. |
| ★ CLASSICAL is BOTH | Triggered by C-REACTIVE PROTEIN (innate) OR ANTIBODY (adaptive). |
| PROPERDIN (factor P) | INCREASES activation — binds C3 convertase on microbial surfaces. |
| FACTOR H + FACTOR I | REDUCE activation — H makes C3b cleavable by I → iC3b, which cannot form a convertase. |
| MEMBRANE regulators | DECAY ACCELERATING FACTOR (DAF) and MEMBRANE COFACTOR PROTEIN (MCP) disrupt C3bBb on HUMAN cells. |
| OPSONIN | A protein bound to a pathogen that FACILITATES PHAGOCYTOSIS. C3b is the opsonin. |
| CR1 | Binds C3b → phagocytosis; ALSO protects human cells by disrupting C3 convertase. |
| C5a | RECRUITS NEUTROPHILS + MOST POTENT ANAPHYLATOXIN. |
| C5b | INITIATES THE MEMBRANE ATTACK COMPLEX. |
| MAC protection | S PROTEIN, CLUSTERIN, FACTOR J block C5b/C6/C7. CD59 (PROTECTIN) and HRF block C9. |
| ★ THE EVASION — and its exception | STREP PYOGENES and STAPH AUREUS coat in SIALIC ACID, which FACTOR H binds → their C3b is inactivated. ANTIBODY MASKS THE SIALIC ACID — so they resist complement ONLY WHEN NO SPECIFIC ANTIBODY IS PRESENT. |
| C3a and C5a in extremis | ANAPHYLACTIC SHOCK. |
| Term | What you need to know |
|---|---|
| ★ THE ONE THING | INTERFERON DOES NOT KILL VIRUSES. It STOPS SPREAD TO SURROUNDING TISSUE. |
| ALPHA | From LYMPHOCYTES and MACROPHAGES. ACTIVATES NK CELLS. |
| BETA | From FIBROBLASTS and EPITHELIAL CELLS. Assists B and T CELL MATURATION + inflammatory response. |
| GAMMA | From T CELLS. INHIBITS CANCER CELLS, STIMULATES B CELLS, ACTIVATES MACROPHAGES. |
| HOW IT PROTECTS | Binds cell surfaces → INDUCES ANTIVIRAL PROTEINS. Also INHIBITS CANCER GENES and SUPPRESSES TUMORS. |
| PLASMACYTOID DENDRITIC CELLS | Professional interferon producers — within 6 HOURS, 60% of transcription is type 1 interferon. |
| Term | What you need to know |
|---|---|
| ★ NEUTROPHILS | 55–90% · LOBED nuclei, LAVENDER granules · PHAGOCYTES. |
| ★ EOSINOPHILS | 1–3% · ORANGE granules, BILOBED · destroy EUKARYOTIC pathogens · MINOR phagocyte. |
| ★ BASOPHILS | 0.5% · CONSTRICTED nuclei, DARK BLUE granules · release POTENT CHEMICAL MEDIATORS. |
| ★ MONOCYTES/MACROPHAGES | 3–7% · LARGEST WBC, KIDNEY-SHAPED nucleus · phagocytic, HOUSEKEEPING, ANTIGEN PRESENTATION, cytokines. |
| ★ LYMPHOCYTES | 20–35% · B (adaptive humoral) · T (adaptive cell-mediated) · NON-B NON-T incl. NK = INNATE. |
| MAST CELLS | Related to basophils but NONMOTILE and CONNECTIVE-TISSUE BOUND. Common progenitor UNSURE. |
| MACROPHAGE origin | FINAL DIFFERENTIATION OF A MONOCYTE, in tissue. |
| DIFFERENTIAL COUNT — what it does | Totals EACH TYPE and asks whether they are in NORMAL PROPORTION — proportion, not just total. |
| DIFFERENTIAL — 6 USES | INFECTION TYPES · INFLAMMATION · ALLERGIES · IMMUNE DISORDERS · LEUKEMIA · MYELODYSPLASTIC SYNDROME. |
| MACROPHAGE vs NEUTROPHIL | MACROPHAGE: LONG-LIVED, tissue-resident, WORKS FIRST and RAISES THE ALARM. NEUTROPHIL: SHORT-LIVED dedicated killer, circulates, WAITS FOR THE ALARM. |
| RESPIRATORY BURST | NADPH OXIDASE → SUPEROXIDE → picks up H ions and RAISES pH so digestive granules can work. |
| LIMITING THE DAMAGE | CATALASE degrades H2O2 → H2O + O2. |
| WHY NEUTROPHILS DIE | They CANNOT REPLENISH GRANULE CONTENTS. |
| PUS | DEAD ORGANISMS + DEAD NEUTROPHILS + DEAD TISSUE. |
| NETOSIS | Neutrophil BURSTS — DNA and defensive proteins form a NEUTROPHIL EXTRACELLULAR TRAP (NET). |
| DENDRITIC CELLS | Patrol tissue, take antigen to the NEAREST LYMPH NODE. An IMMATURE one FAILS TO MAKE A GOOD CONNECTION for activation. |
| Term | What you need to know |
|---|---|
| NK CELLS kill | Cells infected by VIRUSES, BACTERIA or PROTOZOAN PARASITES — INTRACELLULAR infection. |
| CD56 DIM vs BRIGHT | DIM = KILLING virally infected cells. BRIGHT = CYTOKINE SECRETION to maintain inflammation. |
| UTERINE NK (uNK) | CD56 BRIGHT — work with FETAL TROPHOBLASTS to enlarge the SPIRAL ARTERIES. PREECLAMPSIA postulated to involve abnormal KIR activity, MORE INHIBITORY than activating. |
| NK CYTOTOXICITY rises | 20–100 FOLD on exposure to type 1 interferons. |
| WHICH STIMULUS, WHICH FUNCTION | IFN-α/β → favors CYTOTOXICITY. IL-12 → favors CYTOKINE PRODUCTION. |
| ★ THE ONE REQUIREMENT | NK receptors MUST INHIBIT KILLING OF HEALTHY SELF-CELLS. Killing happens when ACTIVATING > INHIBITORY. |
| HOW NK KILLS | Releases CYTOTOXIC GRANULES → APOPTOSIS. Target shrinks, chromatin condenses. MACROPHAGE cleans up. |
| NK ↔ MACROPHAGE | Macrophages RECRUIT and ACTIVATE NK; NK return IFN-γ which enhances macrophage phagocytosis. |
| IF NK CANNOT COPE | They stimulate DENDRITIC CELLS → secondary lymphoid tissue → ADAPTIVE response. Control passes to T CELLS. |
| ILC1 / ILC2 / ILC3 | ILC1 = INTRACELLULAR (hold till NK arrive). ILC2 = MUCOSAL, LARGE EXTRACELLULAR PARASITES (worms). ILC3 = EXTRACELLULAR BACTERIA and FUNGI. |
| LTi CELLS | LYMPHOID TISSUE INDUCER — facilitate development of SECONDARY LYMPHOID TISSUE. |
| PRIMARY lymphoid organs | THYMUS → T cells. BONE MARROW → B cells. |
| SECONDARY lymphoid | SPLEEN, LYMPH NODES, SALT (skin), MALT (mucosal), GALT (gut — PEYER’S PATCHES and APPENDIX), BALT (bronchial). |
| LYMPHATICS reach everywhere EXCEPT | CNS, BONE, PLACENTA, THYMUS. |
| INDUCED INNATE RESPONSE | 4 HOURS – 4 DAYS. STILL NONSPECIFIC. Macrophages, neutrophils, dendritic cells. |
| ★ THE CLOSING CONTRAST | NO INNATE → infections UNCONTROLLED, and adaptive CANNOT BE DEPLOYED. NO ADAPTIVE → CONTROLLED at first but NEVER CLEARED. Innate is the PREREQUISITE, not the backup. |
| Term | What you need to know |
|---|---|
| THE TWO AXES | ACTIVE (you make it) vs PASSIVE (you receive it) × NATURAL vs ARTIFICIAL. Four boxes — place the scenario. |
| NATURAL ACTIVE | Recovery from infection, INCLUDING subclinical or asymptomatic. |
| NATURAL PASSIVE | MATERNAL ANTIBODY — placenta, then milk. 99% is acquired IN UTERO. |
| ARTIFICIAL ACTIVE | VACCINATION. Degree and duration vary by disease. |
| ARTIFICIAL PASSIVE | IMMUNOTHERAPY — pooled serum (gamma globulin) or donor antibody. Hepatitis A, rabies, tetanus. |
| SPECIES IMMUNITY | A special type of INNATE immunity — illnesses we cannot get BECAUSE we are human. |
| ANTIBODY TITRES | What tells you whether a vaccine on your record is still effective, or whether you need a booster. |
| Term | What you need to know |
|---|---|
| ★ THE MNEMONIC | “NEVER LET MONKEYS EAT BANANAS” — Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils. HIGHEST to LOWEST. |
| The figures (from L5) | Neutrophils 55–90% · Lymphocytes 20–35% · Monocytes 3–7% · Eosinophils 1–3% · Basophils 0.5%. |
| MHC = ? | MAJOR HISTOCOMPATIBILITY COMPLEX, also called HUMAN LEUKOCYTE ANTIGEN (HLA). |
| ★ WHERE MHC IS NOT | On ALL cells EXCEPT RED BLOOD CELLS. |
| ★ WHICH CHROMOSOME | CHROMOSOME 6, in a multi-gene complex of classes I, II, III. |
| MHC does two jobs | RECOGNITION OF SELF, and REJECTION OF FOREIGN TISSUE. |
| ★ CLASS I | Displays self molecules. Read by CYTOTOXIC (Tc) T CELLS. |
| ★ CLASS II | The IMMUNE REGULATORY receptors. On MACROPHAGES, APCs and B CELLS. REQUIRED for an APC to activate a T HELPER (CD4) cell. |
| Why transplants work at all | Each MHC profile is unique but can be CLOSE ENOUGH to another’s. |
| Term | What you need to know |
|---|---|
| How many genes | MORE THAN 500 are used to build lymphocyte receptors. |
| ★ SELF-REACTIVE CLONES | ELIMINATED before the fetus is harmed. A defect here = inherited autoimmune disorder such as SCID. |
| How big is the naive pool | 1014 to 1018 variations — UP TO A QUINTILLION. |
| ★ THE POINT TO HOLD | SPECIFICITY EXISTS BEFORE THE ANTIGEN DOES. It is pre-programmed. Antigen SELECTS a clone; it does NOT instruct one. Getting this backwards is the classic error. |
| Term | What you need to know |
|---|---|
| B-CELL RECEPTOR | = IMMUNOGLOBULIN. FOUR chains: 2 identical HEAVY + 2 identical LIGHT. Y-shaped. Variable + constant regions. SECRETED as antibody. |
| T-CELL RECEPTOR | TWO parallel chains. Small — “one fork” of the Y. NEVER SECRETED. Recognizes antigen ONLY with MHC. |
| Young vs mature B cell | YOUNG carries a small IgM; MATURE carries IgD. |
| Variable region genes | LOCKED IN for the life of the cell AND its progeny, including memory cells. |
| B-cell maturation | BONE MARROW STROMAL CELLS → migrate to lymph nodes, spleen, GALT. |
| T-cell maturation | The THYMUS and its hormones — which is why the thymus unites the immune and endocrine systems. |
| ★ CD MARKERS | CD = CLUSTER OF DIFFERENTIATION. CD4 = T HELPER. CD8 = T CYTOTOXIC. |
| Term | What you need to know |
|---|---|
| EPITOPE | = ANTIGENIC DETERMINANT. The small molecular group actually recognized. One antigen may carry MANY. |
| ★ SIZE DECIDES | Most antigenic: foreign cells and molecules OVER 100,000 MW, usually large proteins. |
| ★ HAPTEN | UNDER 1,000 MW — NOT antigenic unless attached to a LARGER CARRIER. Drugs, metals, industrial chemicals. This is how occupational LATEX allergy arises. |
| AUTOANTIGEN | Self tissue for which TOLERANCE IS INADEQUATE → some autoimmune disorders. |
| ALLOANTIGEN | A marker of one individual antigenic to ANOTHER OF THE SAME SPECIES → the BLOOD GROUPS and the MHC profile. Incompatibility → transfusion reaction or graft-versus-host disease. |
| HETEROPHILIC | From an UNRELATED SPECIES with similar determinants. Mammalian heart muscle × group A strep cell wall. |
| ★ SUPERANTIGEN | A potent T-CELL STIMULATOR → CYTOKINE STORM. Staph toxins: toxic shock syndrome toxin, enterotoxin. |
| ALLERGEN | Any antigen provoking allergy = TYPE I HYPERSENSITIVITY. Classified by PORTAL OF ENTRY: inhaled · ingested · injected · contact. |
| Term | What you need to know |
|---|---|
| The three-way collaboration | An APC + a T HELPER CELL + an antigen-specific B or T CELL. |
| What the APC does | ALTERS the antigen and attaches it to its CLASS II MHC receptor. |
| ★ INTERLEUKIN 1 | From the APC. Activates the T helper cell. ALSO an ENDOGENOUS PYROGEN → fever and inflammation. |
| ★ INTERLEUKIN 2 | From the ACTIVATED T HELPER. Activates B cells and other T cells. Its DYSREGULATION → LUPUS and RHEUMATOID ARTHRITIS. |
| Swapping these two | Is the easy mistake. IL-1 comes FROM the APC; IL-2 comes FROM the helper. |
| B-cell expansion gives | PLASMA CELLS (secrete antibody) + MEMORY CELLS. |
| ★ MEMORY CELLS | They PAUSE PARTWAY THROUGH MITOSIS — which is why the secondary response is so fast. |
| The naming | B-cell responses = ANTIBODY-MEDIATED (AMI) or HUMORAL-MEDIATED (HMI). T-cell responses = CELL-MEDIATED (CMI). |
| Term | What you need to know |
|---|---|
| Structure | Y-shaped, FOUR chains. Fab = antigen-binding (two of them). Fc = crystallizable, binds immune cells AND allows the SWIVEL. |
| ★ IgG | MONOMER. MOST PREVALENT. The ONLY one crossing the PLACENTA. LONG-TERM IMMUNITY. Huge titre in SECONDARY responses. |
| ★ IgA | MONOMER or DIMER. SECOND most prevalent. MUCOSAL — saliva, tears, colostrum, mucus. Local immunity: enteric, respiratory, genitourinary. |
| ★ IgM | PENTAMER — by far the LARGEST, so TOO BIG for the placenta. FIRST RESPONDER of the primary response. Important COMPLEMENT FIXER. Binds B cells. |
| ★ IgD | MONOMER. HIGH titre in NEWBORNS, very LOW in adults/children. Binds B cells — trigger for activation AND regulation. |
| ★ IgE | MONOMER. LEAST common in serum and SHORTEST-LIVED. ALLERGENS and PARASITIC WORMS. Binds MAST CELLS and BASOPHILS → asthma, anaphylaxis, via histamine. |
| Which two bind B cells? | IgM and IgD. |
| THE FOUR ANTIBODY ACTIONS | AGGLUTINATION · OPSONIZATION · COMPLEMENT FIXATION · NEUTRALIZATION. |
| OPSONIZATION | Coating so phagocytes can engulf. Matters most for SLIPPERY envelopes, WAXY capsules, SLIME layers. Greek: something cooked with food — a coating. |
| NEUTRALIZATION | Blocking the virus’s ATTACHMENT SPIKE PROTEINS so it cannot enter — and making it easier to phagocytose. |
| ★ AGGLUTINATION | CROSS-LINKING adjacent cells. IgM is best — its pentamer has TEN binding sites. |
| COMPLEMENT FIXATION | Antibody binds, complement proteins bind the remaining sites and use PERFORINS to lyse the envelope. |
| Term | What you need to know |
|---|---|
| PRIMARY response | IgM and IgG, with a GRADUAL rise in titre. Plus MEMORY B CELLS. |
| ★ SECONDARY response | RAPID and STRONGER, because of MEMORY CELLS. A much higher titre of IgG, then gradual IgM. |
| Also called | The ANAMNESTIC RESPONSE. |
| Titre unit | BAU — binding antibody units. |
| Does titre reach zero? | In a healthy person with robust responses, NO. |
| T cells need | Activation by SOME TYPE OF MHC MOLECULE. All T cells produce CYTOKINES. |
| ★ THE FOUR T CELLS | TH (CD4) conducts · TC (CD8) lyses virally infected, cancer and foreign cells · TD delayed hypersensitivity (allergy HOURS to DAYS later) · TS suppressor, limits other T and B cells. |
| Sensitized T cells become | LONG-LASTING MEMORY T CELLS. |
| Term | What you need to know |
|---|---|
| PASSIVE immunization lasts | TWO TO THREE MONTHS. |
| HORSE SERUM | Early antitoxins for tetanus and diphtheria. STILL used for diphtheria, botulism, spider/snake bites. Risks: SERUM SICKNESS, ANAPHYLAXIS. |
| POOLED GAMMA GLOBULIN | Hepatitis A, hepatitis B, HIV, measles, generally immunodeficient patients. |
| ★ -mab | MONOCLONAL ANTIBODY (a protein). |
| ★ -omab | MOUSE. |
| ★ -ximab | CHIMERIC. |
| ★ -zumab | HUMANIZED. |
| ★ -umab | ENTIRELY HUMAN. |
| Two examples | ADALIMUMAB (Humira) — RA, psoriatic arthritis, Crohn, plaque psoriasis. PEMBROLIZUMAB (Keytruda) — melanoma, lung cancer. |
| VACCINATION is | Deliberate exposure to material that is ANTIGENIC BUT NOT PATHOGENIC. |
| The history | LADY MONTAGU brought it to England · JENNER gave the first effective human vaccination (COWPOX → SMALLPOX) · PASTEUR later did RABIES. |
| ★ AN EFFECTIVE VACCINE | Low toxicity · protects on exposure · stimulates BOTH AMI AND CMI · produces MEMORY B and T cells · generally NOT many doses · cheap, easy, long shelf-life. |
| STERILIZING vaccine | The best option — the target is rendered NON-FUNCTIONING and UNABLE TO MUTATE. |
| Vaccine contents | Killed whole cells / inactivated virus · LIVE ATTENUATED · acellular or subunit antigens · TOXOIDS · genetically engineered. |
| ★ MARROW DONATION | Requires a close CLASS I MHC match plus DNA testing. Harvested from STERNUM, FEMUR or ILIAC CREST. Peripheral stem cells by APHERESIS after a mobilizing drug. The RECIPIENT gets drug and radiation therapy first, TO REDUCE REJECTION RISK. |